神經血管裝置市場 - 成長，趨勢，預測(2019 - 2024)

全球神經血管裝置市場在2019年∼2024年間，預測將以7.7％的年複合成長率擴大。

本報告提供全球神經血管裝置市場調查，市場概要，各類型、用途、終端用戶、地區的市場趨勢，市場規模的變化與預測，市場促進、阻礙因素以及市場機會分析，競爭情形，主要企業的簡介等全面性資訊。

目錄

第1章 簡介

• 調查成果
• 調查的前提條件
• 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

• 市場概況
• 成長要素
• 阻礙因素
• 波特的五力分析
  • 新加入廠商的威脅
  • 消費者談判力
  • 供應商談判力
  • 替代產品的威脅
  • 產業內的競爭

第5章 市場區隔

• 各產品
  • 動脈瘤線圈 & 栓塞設備
  • 腦動脈球囊血管新生、支架系統
  • 支援設備
  • 腦血栓消除設備
  • 其他
• 目標疾病
  • 缺血性中風
  • 腦動脈瘤
  • 動靜脈畸形、動靜脈瘺
  • 其他
• 各地區
  • 北美
  • 歐洲
  • 亞太地區
  • 中東、非洲
  • 南美

第6章 競爭情形

• 企業簡介
  • Abbott Laboratories
  • Johnson & Johnson (DePuy Synthes)
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Stryker Corporation
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.

第7章 市場機會及未來趨勢

Global Neurovascular Devices market is expected to witness a CAGR of 7.7% during the forecast period. Certain factors that are driving the market growth include increasing target patient population, ongoing product development and commercialization, and rising research activities in the field of neurovascular therapies.

Vascular diseases involving the cerebral circulation characterize a complex as well as miscellaneous spectrum of pathology. Over the past few years, within the cerebrovascular field, a number of recent advances have taken place regarding patient diagnosis, imaging analysis, evaluation, microsurgical treatments, medical therapies, and minimally invasive therapeutic modalities. All these improvements have been propelled by research developments from in vivo, in vitro, translational, as well as clinical studies. Neurovascular disorders, including arteriovenous malformations (AVMs), brain aneurysms, carotid artery disease, along with intracranial atherosclerotic disease, take an enormous health and economic toll on the world population and can result in lots of neurological problems ranging from subarachnoid hemorrhage and stroke to disability and even death.

Key Market Trends

Ischemic Strokes is Expected to Hold Significant Market Share in the Target Disease Segment

Ischemic stroke is referred to a heterogeneous multifactorial disease characterized by the sudden onset of neurologic signs that are directly related to the places of injury in the brain where the morbid process takes place. The evaluation of multifaceted neurologic disorders, including stroke, in which a large number of genetic and epigenetic factors interact with even the environmental risk factors in order to increase the risk has been revolutionized by the GWAS (genome-wide association studies) approach. According to the Stroke Center, the US, the risk of ischemic stroke in current smokers is around two-fold higher than that of nonsmokers after fine-tuning with other risk factors. Hence, with increasing smoking population the prevalence of the disease is expected to rise significantly over the forecast period, thus contributing to the market growth.

North America Dominates the Market and Expected to do Same in the Forecast Period

According to the Centers for Disease Control and Prevention (CDC) facts (2017), stroke results in the death of about 140,000 Americans each year which is 1 out of every 20 deaths. In the United States, there is estimated to be at least one stroke within every 40 seconds and every four minutes, someone dies of a stroke. Approximately 87% of all strokes are ischemic strokes, in which blood flow to the brain gets blocked. Similarly, as per stated by the Brain Aneurysm Foundation (2019), cerebral aneurysms affect an estimated 6 million Americans and are accountable for nearly half a million deaths worldwide each year, with half the victim's age 50 and younger. All these factors are expected to fuel the overall market growth across the region.

Competitive Landscape

The global Neurovascular Devices market is highly competitive and consists of a few major players. Companies like Abbott Laboratories, Johnson & Johnson, Medtronic plc, MicroPort Scientific Corporation, Penumbra, Inc., Stryker Corporation, Terumo Corporation, W. L. Gore & Associates, Inc., among others, hold the substantial market share in the Neurovascular Devices market.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Deliverables
• 1.2 Study Assumptions
• 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Target Patient Population
  • 4.2.2 Ongoing Product Development and Commercialization
  • 4.2.3 Rising Research Activities in the Field of Neurovascular Therapies
• 4.3 Market Restraints
  • 4.3.1 Stringent Regulations
  • 4.3.2 Dearth of Skilled Neurosurgeons
• 4.4 Porter's Five Force Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 Product
  • 5.1.1 Aneurysm Coiling & Embolization Devices
  • 5.1.2 Cerebral Balloon Angioplasty and Stenting Systems
  • 5.1.3 Support Devices
  • 5.1.4 Neurothrombectomy Devices
  • 5.1.5 Other Devices (Revascularization Devices etc.)
• 5.2 Target Disease
  • 5.2.1 Ischemic Strokes
  • 5.2.2 Cerebral Aneurysms
  • 5.2.3 Arteriovenous Malformation and Fistulas
  • 5.2.4 Other Target Diseases (Stenosis etc.)
• 5.3 Geography
  • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
  • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
  • 5.3.3 Asia Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
  • 5.3.4 Middle East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle East and Africa
  • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Abbott Laboratories
  • 6.1.2 Johnson & Johnson (DePuy Synthes)
  • 6.1.3 Medtronic plc
  • 6.1.4 MicroPort Scientific Corporation
  • 6.1.5 Penumbra, Inc.
  • 6.1.6 Stryker Corporation
  • 6.1.7 Terumo Corporation
  • 6.1.8 W. L. Gore & Associates, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS